The rare patients who are able to spontaneously control HIV replication in the absence of therapy show signs of a particularly efficient cellular immune response. To identify the molecular determinants that underlie this response, we characterized the T cell receptor (TCR) repertoire directed at Gag293, the most immunoprevalent CD4 epitope in the HIV-1 capsid. HIV controllers from the ANRS CODEX cohort showed a highly skewed TCR repertoire that was characterized by a predominance of
Daniela Benati, Moran Galperin, Olivier Lambotte, Stéphanie Gras, Annick Lim, Madhura Mukhopadhyay, Alexandre Nouël, Kristy-Anne Campbell, Brigitte Lemercier, Mathieu Claireaux, Samia Hendou, Pierre Lechat, Pierre de Truchis, Faroudy Boufassa, Jamie Rossjohn, Jean-François Delfraissy, Fernando Arenzana-Seisdedos, Lisa A. Chakrabarti
Title and authors | Publication | Year |
---|---|---|
HIV controllers: hope for a functional cure
Deng Z, Yan H, Lambotte O, Moog C, Su B |
Frontiers in Immunology | 2025 |
Re-centauring T cell antigen discovery around CD4(+) T cells.
Smith BE, Chan AO, Birnbaum ME |
2024 | |
High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits.
Kohlgruber AC, Dezfulian MH, Sie BM, Wang CI, Kula T, Laserson U, Larman HB, Elledge SJ |
Nature biotechnology | 2024 |
A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design
Sengupta S, Zhang J, Reed MC, Yu J, Kim A, Boronina TN, Board NL, Wrabl JO, Shenderov K, Welsh RA, Yang W, Timmons AE, Hoh R, Cole RN, Deeks SG, Siliciano JD, Siliciano RF, Sadegh-Nasseri S |
Journal of Experimental Medicine | 2023 |
Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens
Mattila J, Sormunen S, Heikkilä N, Mattila IP, Saramäki J, Arstila TP |
Cancer Medicine | 2023 |
Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells.
Zhou Y, Jadlowsky J, Baiduc C, Klattenhoff AW, Chen Z, Bennett AD, Pumphrey NJ, Jakobsen BK, Riley JL |
PLoS pathogens | 2023 |
TScan-II: A genome-scale platform for de novo identification of CD4+ T-cell epitopes
Dezfulian MH, Kula T, Pranzatelli T, Kamitaki N, Meng Q, Khatri B, Perez P, Xu Q, Chang A, Kohlgruber AC, Leng Y, Jupudi A, Joachims ML, Chiorini JA, Lessard CJ, Farris AD, Muthuswamy S, Warner BM, Elledge SJ |
Cell | 2023 |
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine
S Chen, Y Wong, L Yim, H Zhang, H Wang, G Lui, X Li, X Tang, L Cheng, Y Du, Q Peng, J Wang, H Kwok, H Huang, T Lau, D Chan, B Wong, L Liu, L Chakrabarti, S Lee, Z Chen, G Silvestri |
Journal of virology | 2022 |
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
M Claireaux, R Robinot, J Kervevan, M Patgaonkar, I Staropoli, A Brelot, A Nouël, S Gellenoncourt, X Tang, M Héry, S Volant, E Perthame, V Avettand-Fenoël, J Buchrieser, T Cokelaer, C Bouchier, L Ma, F Boufassa, S Hendou, V Libri, M Hasan, D Zucman, P de Truchis, O Schwartz, O Lambotte, L Chakrabarti |
Nature Communications | 2022 |
A nano-enhanced vaccine for metastatic melanoma immunotherapy
Salotto KE, Olson Jr WC, Pollack KE, Illendula A, Michel E, Henriques S, Fox T, Walker S, Dunlap-Brown M, Slingluff Jr CL, Kester M, Snyder HW |
2022 | |
HIV-1-infected CD4+ T cells present MHCII-restricted epitope via endogenous processing
Addison MM, Ellis GI, Leslie GJ, Zawadzky NB, Riley JL, Hoxie JA, Eisenlohr LC |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
Perturbations in the T cell receptor β repertoire during malaria infection in children: A preliminary study.
Frimpong A, Ofori MF, Degoot AM, Kusi KA, Gershom B, Quartey J, Kyei-Baafour E, Nguyen N, Ndifon W |
Frontiers in immunology | 2022 |
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
Muvarak N, Li H, Lahusen T, Galvin JA, Kumar PN, Pauza CD, Bordon J |
Frontiers in Medicine | 2022 |
Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19
Ogura H, Gohda J, Lu X, Yamamoto M, Takesue Y, Son A, Doi S, Matsushita K, Isobe F, Fukuda Y, Huang TP, Ueno T, Mambo N, Murakami H, Kawaguchi Y, Inoue JI, Shirai K, Yamasaki S, Hirata JI, Ishido S |
Nature Communications | 2022 |
Elite and posttreatment controllers, two facets of HIV control.
Mastrangelo A, Banga R, Perreau M |
Current Opinion in HIV and AIDS | 2022 |
The discriminatory power of the T cell receptor
J Pettmann, A Huhn, EA Shah, MA Kutuzov, DB Wilson, ML Dustin, SJ Davis, PA van der Merwe, O Dushek |
eLife | 2021 |
Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions
J Kervevan, LA Chakrabarti |
International journal of molecular sciences | 2021 |
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells
K Sugata, Y Matsunaga, Y Yamashita, M Nakatsugawa, T Guo, L Halabelian, Y Ohashi, K Saso, MA Rahman, M Anczurowski, CH Wang, K Murata, H Saijo, Y Kagoya, D Ly, BD Burt, MO Butler, TW Mak, N Hirano |
Nature Biotechnology | 2021 |
Clustering based approach for population level identification of condition-associated T-cell receptor β-chain CDR3 sequences
DA Yohannes, K Kaukinen, K Kurppa, P Saavalainen, D Greco |
BMC bioinformatics | 2021 |
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
TH Nguyen, M Koutsakos, CE van de Sandt, JC Crawford, L Loh, S Sant, L Grzelak, EK Allen, T Brahm, EB Clemens, M Auladell, L Hensen, Z Wang, S Nüssing, X Jia, P Günther, AK Wheatley, SJ Kent, M Aban, YM Deng, KL Laurie, AC Hurt, S Gras, J Rossjohn, J Crowe, J Xu, D Jackson, LE Brown, NL Gruta, W Chen, PC Doherty, SJ Turner, TC Kotsimbos, PG Thomas, AC Cheng, K Kedzierska |
Nature Communications | 2021 |
Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
L Plaçais, F Boufassa, C Lécuroux, E Gardiennet, V Avettand-Fenoel, A Saez-Cirion, O Lambotte, N Noël |
2021 | |
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
YH Teng, HS Quah, L Suteja, JM Dias, A Mupo, RJ Bashford-Rogers, GS Vassiliou, ML Chua, DS Tan, DW Lim, NG Iyer |
Cancer Immunology, Immunotherapy | 2021 |
Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells
H Loucif, X Dagenais-Lussier, D Avizonis, L Choinière, C Beji, L Cassin, JP Routy, JH Fritz, D Olagnier, J van Grevenynghe |
Autophagy | 2021 |
Distinct antibody profiles in HLA-B ∗ 57 + , HLA-B ∗ 57 − HIV controllers and chronic progressors
J Klingler, N Paul, G Laumond, S Schmidt, L Mayr, T Decoville, O Lambotte, B Autran, S Bahram, C Moog |
AIDS | 2021 |
HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells
S Sant, SM Quiñones-Parra, M Koutsakos, EJ Grant, T Loudovaris, SI Mannering, J Crowe, CE van de Sandt, GF Rimmelzwaan, J Rossjohn, S Gras, L Loh, TH Nguyen, K Kedzierska, S Schultz-Cherry |
PLoS pathogens | 2020 |
The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
DS Chatzileontiadou, H Sloane, AT Nguyen, S Gras, EJ Grant |
International journal of molecular sciences | 2020 |
Escherichia coli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease
AM Uchida, EK Boden, EA James, DM Shows, AJ Konecny, J D. |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2020 |
CD4+ T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features
A Greenshields-Watson, M Attaf, BJ MacLachlan, T Whalley, C Rius, A Wall, A Lloyd, H Hughes, KE Strange, GH Mason, AJ Schauenburg, SL Hulin-Curtis, J Geary, Y Chen, SN Lauder, K Smart, D Vijaykrishna, ML Grau, M Shugay, R Andrews, G Dolton, PJ Rizkallah, AM Gallimore, AK Sewell, AJ Godkin, DK Cole |
Cell Reports | 2020 |
A Conserved TCRβ Signature Dominates a Highly Polyclonal T-Cell Expansion During the Acute Phase of a Murine Malaria Infection
NL Smith, W Nahrendorf, C Sutherland, JP Mooney, J Thompson, PJ Spence, GJ Cowan |
Frontiers in immunology | 2020 |
T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation
T Toya, A Taguchi, K Kitaura, F Misumi, Y Nakajima, Y Otsuka, R Konuma, H Adachi, A Wada, Y Kishida, T Konishi, A Nagata, Y Yamada, A Marumo, Y Noguchi, K Yoshifuji, J Mukae, K Inamoto, A Igarashi, Y Najima, T Kobayashi, K Kakihana, K Ohashi, R Suzuki, T Nagamatsu, N Doki |
Scientific Reports | 2020 |
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy: TCR Sequencing of Virus-specific T-cells
MD Keller, S Darko, H Lang, A Ransier, CA Lazarski, Y Wang, PJ Hanley, BJ Davila, JR Heimall, RF Ambinder, AJ Barrett, CM Rooney, HE Heslop, DC Douek, CM Bollard |
British Journal of Haematology | 2019 |
Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection
L Li, Y Liu, MK Gorny |
Frontiers in immunology | 2018 |
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers
M Claireaux, M Galperin, D Benati, A Nouël, M Mukhopadhyay, J Klingler, P Truchis, D Zucman, S Hendou, F Boufassa, C Moog, O Lambotte, LA Chakrabarti, V Simon, P Palese |
mBio | 2018 |
Understanding the CD8 T-cell response in natural HIV control
S Boppana, P Goepfert |
F1000Research | 2018 |
T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable
AV Joglekar, Z Liu, JK Weber, Y Ouyang, JD Jeppson, WJ Noh, PA Lamothe-Molina, H Chen, S Kang, MT Bethune, R Zhou, BD Walker, D Baltimore |
Proceedings of the National Academy of Sciences | 2018 |
Dendritic Cell Immune Responses in HIV-1 Controllers
E Martin-Gayo, XG Yu |
Current HIV/AIDS Reports | 2017 |
Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance
MS Abdel-Hakeem, M Boisvert, J Bruneau, H Soudeyns, NH Shoukry, G Randall |
PLoS pathogens | 2017 |
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection
A Rouers, J Klingler, B Su, A Samri, G Laumond, S Even, V Avettand-Fenoel, C Richetta, N Paul, F Boufassa, L Hocqueloux, H Mouquet, C Rouzioux, O Lambotte, B Autran, S Graff-Dubois, C Moog, A Moris |
EBioMedicine | 2017 |
High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities
JM Heather, M Ismail, T Oakes, B Chain |
Briefings in Bioinformatics | 2017 |
Chronic infections with viruses or parasites: breaking bad to make good
A Godkin, KA Smith |
Immunology | 2017 |
DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers
M Mukhopadhyay, M Galperin, M Patgaonkar, S Vasan, DD Ho, A Nouël, M Claireaux, D Benati, O Lambotte, Y Huang, LA Chakrabarti |
Journal of immunology (Baltimore, Md. : 1950) | 2017 |
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients
M Galperin, D Benati, M Claireaux, M Mukhopadhyay, L Chakrabarti |
Bio-protocol | 2017 |
Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion
S Ranasinghe, PA Lamothe, DZ Soghoian, SW Kazer, MB Cole, AK Shalek, N Yosef, RB Jones, F Donaghey, C Nwonu, P Jani, GM Clayton, F Crawford, J White, A Montoya, K Power, TM Allen, H Streeck, DE Kaufmann, LJ Picker, JW Kappler, BD Walker |
Immunity | 2016 |